Home - Xtalks

Xtalks — The Life Science Community™

Xtalks connects industry professionals to share the latest in pharma, biotech, medtech, healthcare and research.

Join free for webinars, articles, videos, job postings and more.

Xtalks — The Life Science Community™

Xtalks connects industry professionals to share the latest in pharma, biotech, medtech, healthcare and research.

Join free for webinars, articles, videos, job postings and more.

Upcoming Webinars

View All

May 07, 2026

AI and Emerging Technologies in Clinical Trials: Practical Applications and Regulatory Considerations

May 12, 2026

Media Manufacturing Strategies to Reduce GMP Transition Risk

May 12, 2026

Enhance Neurodegenerative Detection and Monitoring with BD-pTau 217 and α-Syn

May 12, 2026

Chronic Inflammatory Dermatoses: Designing Trials for Late-Stage Success

May 13, 2026

Neuroscience Drug Development: How Novel Applications of AI Could Meaningfully Disrupt Traditional Development Strategies

May 19, 2026

How AI Can Reduce Inspection Risk and Strengthen QMSR Readiness

May 20, 2026

Using AI to Responsibly Accelerate Clinical Trials Under Regulatory Scrutiny

May 20, 2026

Measuring What Matters in ALS: The ALSFRS-R

May 07, 2026

AI and Emerging Technologies in Clinical Trials: Practical Applications and Regulatory Considerations

May 12, 2026

Media Manufacturing Strategies to Reduce GMP Transition Risk

May 12, 2026

Enhance Neurodegenerative Detection and Monitoring with BD-pTau 217 and α-Syn

May 12, 2026

Chronic Inflammatory Dermatoses: Designing Trials for Late-Stage Success

May 13, 2026

Neuroscience Drug Development: How Novel Applications of AI Could Meaningfully Disrupt Traditional Development Strategies

May 19, 2026

How AI Can Reduce Inspection Risk and Strengthen QMSR Readiness

May 20, 2026

Using AI to Responsibly Accelerate Clinical Trials Under Regulatory Scrutiny

May 20, 2026

Measuring What Matters in ALS: The ALSFRS-R

On-Demand Webinars

View All

May 06, 2026

MRD-Driven Oncology Trials: Regulatory, Clinical and Pharmacology Considerations

April 30, 2026

Use Profiling Data to Reduce PROTACs and RIPTACs Program Delays

April 30, 2026

Redefining Hematologic Malignancy Drug Development: How Molecular Reclassification, MRD, & AI is Reshaping Precision Hematology

April 28, 2026

How Objective Sleep Biomarkers Improve Clinical Development and Clinical Assessment in Depression

May 06, 2026

MRD-Driven Oncology Trials: Regulatory, Clinical and Pharmacology Considerations

April 30, 2026

Use Profiling Data to Reduce PROTACs and RIPTACs Program Delays

April 30, 2026

Redefining Hematologic Malignancy Drug Development: How Molecular Reclassification, MRD, & AI is Reshaping Precision Hematology

April 28, 2026

How Objective Sleep Biomarkers Improve Clinical Development and Clinical Assessment in Depression

Featured Editorial

Vitals

Your source for industry focused blog articles, news, videos, polls & quizzes

View All

World Ovarian Cancer Day 2026: New Diagnostics and ADCs

Blogs May 6, 2026

AstraZeneca’s Camizestrant Hit by FDA Advisory Committee Vote While Truqap Moves Ahead

News May 6, 2026

Mirum’s Volixibat Hits Main Goal in Rare Liver Disease Study

News May 6, 2026

World Ovarian Cancer Day 2026: New Diagnostics and ADCs

Blogs May 6, 2026

AstraZeneca’s Camizestrant Hit by FDA Advisory Committee Vote While Truqap Moves Ahead

News May 6, 2026

Mirum’s Volixibat Hits Main Goal in Rare Liver Disease Study

News May 6, 2026

Vitals

Your source for industry focused blog articles, news, videos, polls & quizzes

View All